Transcriptional regulation of human eosinophil RNase2 by the liver-enriched hepatocyte nuclear factor 4.
Human eosinophil-derived neurotoxin (EDN, RNase2) and eosinophil cationic protein (ECP, RNase3) sequences possess as high as 92% identity in their promoter regions. The major difference within this region is a 34-nucleotide (34-nt) segment appeared only in the edn promoter. In addition, six discrete segments existed in the regulatory regions of both edn and ecp. Our previous study indicated that the 34-nt segment is responsive for higher transcription activity of edn in comparison with ecp, via binding to transcription activator Sp1. In this study, the roles of the six discrete segments in transcription regulation were investigated and the -350/-329 region (ednR2) was shown to be involved in the regulation of edn expression. When the ednR2 segment of edn was replaced with that of ecp, a significant decrease in edn promoter activity was detected. Supershift, chromatin immunoprecipitation, and DNA affinity precipitation assays further showed that a transcription factor HNF4 bound to the ednR2 region of edn promoter in vitro. Interestingly, HNF4 overexpression resulted in the reduction of edn promoter activity in HepG2 cells, due to involvement of both ednR2 and the 34-nt regions, and direct interaction between HNF4 and Sp1, which abolishes Sp1 binging to the 34-nt segment. Moreover, when the Sp1 was depleted in the cell, overexpressed HNF4 enhanced edn promoter activity. Our results provide novel mechanisms for HNF4 function as an activator to regulate edn promoter activity, which account for differential transcription regulation of human eosinophil RNases.
Wang
Hsiu-Yu
HY
Institute of Molecular and Cellular Biology & Department of Life Science, National Tsing Hua University, No. 101, Sec. 2, Kuang-Fu Rd., Hsinchu, Taiwan 30013, Republic of China.
Ho
Po-Chun
PC
Lan
Chung-Yu
CY
Chang
Margaret Dah-Tsyr
MD
D045744:Cell Line, Tumor; D047150:Eosinophil Cationic Protein / Q000378:metabolism; D047208:Eosinophil-Derived Neurotoxin / Q000235:genetics / Q000378:metabolism*; D004804:Eosinophils / Q000201:enzymology*; D005786:Gene Expression Regulation / Q000235:genetics*; D051557:Hepatocyte Nuclear Factor 4 / Q000378:metabolism*; D006801:Humans; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding; D016329:Sp1 Transcription Factor / Q000378:metabolism; D014158:Transcription, Genetic / Q000235:genetics*
D051557:Hepatocyte Nuclear Factor 4; D016329:Sp1 Transcription Factor; D047208:Eosinophil-Derived Neurotoxin; D047150:Eosinophil Cationic Protein